Rocio Evangelista

Rocio Evangelista is a veterinarian by training and an expert in preclinical oncology research, currently serving as Head of Preclinical Pharmacology. With a career spanning major industry leaders like Roche, she specializes in driving preclinical candidate validation across two key pillars: Immuno-Oncology (IO) and Radioligand Therapy (RLT). Her work focuses on bridging innovative drug design with robust in vivo profiling to accelerate next-generation cancer therapies into the clinic.